Form 4: Ginkgo Bioworks Executive Steven P. Coen Reports Stock Transactions

Steven P. Coen, Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units to cover tax obligations.

Summary

• On April 17, 2025, Steven P. Coen, Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., engaged in multiple transactions involving Class A Common Stock and Restricted Stock Units (RSUs).
• These transactions included the acquisition of shares through the vesting of RSUs and the disposal of shares to cover tax withholding obligations.
• Specifically, Coen acquired 587, 156, and 1,061 shares of Class A Common Stock through RSU vesting on April 17, 2025.
• He also sold 997 shares on April 21, 2025, at a price of $7.283 per share to cover tax obligations related to the vesting of restricted stock and/or RSUs.
• Following these transactions, Coen directly owns 8,819 shares of Class A Common Stock and holds derivative securities including 14,688, 5,471, and 3,184 Restricted Stock Units.
• The RSUs vest in installments, with varying schedules depending on the grant date.

Sentiment

Score: 5

Explanation: This is a routine filing related to stock transactions by a company executive. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information about insider activity.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor potential alignment of interests between management and shareholders.

Stakeholder Impact

• Shareholders can monitor insider transactions to gain insights into management's perspective on the company's stock.

Key Dates

Keywords

Ginkgo Bioworks, DNA, Form 4, SEC Filing, Insider Trading, Steven P. Coen, Restricted Stock Units, Class A Common Stock, Tax Withholding